Axol Bioscience Ltd.
United Kingdom
- Cambridge, Cambridgeshire
- 15/01/2026
- Unknown
- $28,000,000
Axol Bioscience is a leading provider of human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of high-performance iPSC-derived cells and the delivery of industry-leading laboratory services. With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use of iPSC-based models in drug discovery and disease research.
We operate across five key areas, neuroscience (including ALS, Alzheimer’s, Huntington’s, Parkinson’s, neuroinflammation), pain & sensation, ophthalmology (Dry-AMD, ophthal-inflammation), dermatology, and cardiovascular.
Axol offers scalable solutions including iPSC banking, reprogramming, gene editing, cell manufacturing, and quality control. The company is committed to closing the translational gap, developing physiologically relevant in vitro systems that improve consistency and relevance in human disease modeling and compound testing.
Axol is recognized for its scientific excellence, transparent collaboration, and rigorous quality standards, with manufacturing operations certified to ISO 9001:2015.
- Industry Biotechnology Research
- Website https://axolbio.com/
- LinkedIn https://www.linkedin.com/company/axol-bioscience-ltd-/
Related People
Liam TaylorFounder
United Kingdom -
Greater Cambridge Area
Growth mindset and focus that comes with comprehensive experience of financial, operational and company management, competent at running operations, divisions or entire companies. Financially trained and experienced, with commercial acumen, able to see the big picture, understand underlying business issues and opportunities, and translate them into strategies, plans and actions, which will be implemented with considerable drive and determination. A genuine “people person”, collaborative team builder, charismatic and inspiring leader, able to recruit, train and develop multi-function teams to achieve high levels of performance. Skilled and passionate about communication and negotiation, able to build trust, influence and persuade people at all levels, and in all job functions. Adept at prioritising, addressing the most important issues, and understanding financial implications and analysing financial statements, which together with personal gravitas, brings “commercial wisdom” to the Board. Suited to turnarounds, running high growth businesses / operations, and taking successful organisations / operations to the next level.
osapiens | $100,000,000 | (Jan 15, 2026)
Musical AI | $4,500,000 | (Jan 15, 2026)
Harmattan AI | $200,000,000 | (Jan 15, 2026)
Tive | $20,000,000 | (Jan 15, 2026)
IO River | $20,000,000 | (Jan 15, 2026)
Flip (US) | $20,000,000 | (Jan 15, 2026)
MeetCaria | $1,000,000 | (Jan 15, 2026)
SkyFi | $12,700,000 | (Jan 15, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)